Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Bausch Health Companies Inc.

BHC · NYSE · CIK 0000885590 · Healthcare · Drug Manufacturers—Specialty & Generic

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

20 Form 4 transaction lines observed in the same window
2 sales · 18 option, withholding, award, gift or other lines

Last qualifying purchase2025-11-25 · PAULSON & CO. INC. · $15.6M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesLow
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
WECHSLER AMY BDirector
○○○
Paulson JohnDirector
○○○
LEUNG SANDRADirector
○○○
Lenar Aimee J.President, US Pharma
○○▼
Lee Frank D.Director
▼○
ROBERTS EIRYDirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 5 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-11-25 · PAULSON & CO. INC..

Recent Form 4 activity

1Purchases
5Sales
39Other Form 4 lines
34SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING2 sale line(s) · context only
OTHER18 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
+11.5%
3M
+34.6%
6M
+6.8%
12M
+4.7%

Volatility & liquidity

Volatility
56.1%
Beta
—
Avg daily value
USD 20.7M

Valuation

Market cap
—
P/E
—

Fundamentals

Profit margin
1.5%
ROE
—
Industry
Drug Manufacturers—Specialty & Generic

Market data

Price data up to: 2026-10-16 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Profit margin · Fiscal year ended: 2025-12-31 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
8,404,206
Previous report
8,627,598
Avg daily volume
1,739,421
Days to cover
4.8

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-11-25PAULSON & CO. INC.Purchase (P)Common Stock, no par value2,500,000USD 6.25USD 15,625,000SEC filing ↗
2025-08-14Paulson JohnPurchase (P)Common Stock, no par value34,721,118USD 9.00USD 312,490,062SEC filing ↗
2025-08-13Paulson JohnPurchase (P)Common Stock, no par value86,409USD 7.06USD 610,048SEC filing ↗
2025-08-12Paulson JohnPurchase (P)Common Stock, no par value1,156,640USD 6.88USD 7,957,683SEC filing ↗
2025-08-11Paulson JohnPurchase (P)Common Stock, no par value2,000,000USD 6.35USD 12,700,000SEC filing ↗
2025-06-13Paulson JohnPurchase (P)Common Stock, no par value3,564,059USD 5.94USD 21,170,510SEC filing ↗
2025-06-12Paulson JohnPurchase (P)Common Stock, no par value1,005,376USD 5.47USD 5,499,407SEC filing ↗
2025-06-11Paulson JohnPurchase (P)Common Stock, no par value1,029,098USD 5.24USD 5,392,474SEC filing ↗
2025-06-10Paulson JohnPurchase (P)Common Stock, no par value754,134USD 5.05USD 3,808,377SEC filing ↗
2021-11-30Miller Steven DPurchase (P)Common Shares, No Par Value60,000USD 24.23USD 1,453,700SEC filing ↗
2021-08-05VON ESCHENBACH ANDREW C.Purchase (P)Common Shares, No Par Value1,400USD 25.94USD 36,316SEC filing ↗
2021-08-04DE SCHUTTER RICHARD UPurchase (P)Common Shares, No Par Value10,000USD 25.01USD 250,100SEC filing ↗
2020-06-05VA Partners I, LLC; ValueAct Capital Management, L.P.; ValueAct Capital Management, LLC; ValueAct Capital Master Fund, L.P.; ValueAct Co-Invest Master Fund, L.P.; ValueAct Holdings GP, LLC; ValueAct Holdings II, L.P.; ValueAct Holdings, L.P.Purchase (P)Common Shares, no par value948,353USD 19.24USD 18,246,312SEC filing ↗
2020-05-14Paulson JohnPurchase (P)Common Stock, no par value1,628,920USD 15.87USD 25,857,837SEC filing ↗
2020-05-13Paulson JohnPurchase (P)Common Stock, no par value1,330,044USD 16.52USD 21,972,617SEC filing ↗

Form 4 evidence

45 transaction lines in the latest 365-day window; 505 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-30WECHSLER AMY BAward / grant (A)Common Shares, No Par Value1,179USD 5.83USD 6,874SEC filing ↗
2026-09-30Paulson JohnAward / grant (A)Common Shares, No Par Value10,720USD 5.83USD 62,498SEC filing ↗
2026-09-30LEUNG SANDRAAward / grant (A)Common Shares, No Par Value5,789USD 5.83USD 33,750SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-30WECHSLER AMY BAward / grant (A)Common Shares, No Par Value1,179USD 5.83USD 6,874SEC filing ↗
2026-09-30Paulson JohnAward / grant (A)Common Shares, No Par Value10,720USD 5.83USD 62,498SEC filing ↗
2026-09-30LEUNG SANDRAAward / grant (A)Common Shares, No Par Value5,789USD 5.83USD 33,750SEC filing ↗
2026-08-19Lenar Aimee J.Sale (S)Common Shares, No Par Value36,827USD 7.03USD 258,894SEC filing ↗
2026-07-17Lenar Aimee J.Tax withholding (F)Common Shares, No Par Value5,260USD 4.83USD 25,406SEC filing ↗
2026-07-15Lenar Aimee J.Tax withholding (F)Common Shares, No Par Value23,395USD 4.89USD 114,402SEC filing ↗
2026-07-14LEE STEVEN HYOSIGTax withholding (F)Common Shares, No Par Value3,125USD 4.75USD 14,844SEC filing ↗
2026-06-30WECHSLER AMY BAward / grant (A)Common Shares, No Par Value1,394USD 4.93USD 6,872SEC filing ↗
2026-06-30Paulson JohnAward / grant (A)Common Shares, No Par Value12,677USD 4.93USD 62,498SEC filing ↗
2026-06-30LEUNG SANDRAAward / grant (A)Common Shares, No Par Value6,845USD 4.93USD 33,746SEC filing ↗
2026-05-22WECHSLER AMY BAward / grant (A)Common Shares, No Par Value45,871USD 0.00USD 0SEC filing ↗
2026-05-22ROBERTS EIRYAward / grant (A)Common Shares, No Par Value45,871USD 0.00USD 0SEC filing ↗
2026-05-22Paulson JohnAward / grant (A)Common Shares, No Par Value45,871USD 0.00USD 0SEC filing ↗
2026-05-22POWER ROBERT NAward / grant (A)Common Shares, No Par Value45,871USD 0.00USD 0SEC filing ↗
2026-05-22Lee Frank D.Award / grant (A)Common Shares, No Par Value45,871USD 0.00USD 0SEC filing ↗
2026-05-22LEUNG SANDRAAward / grant (A)Common Shares, No Par Value45,871USD 0.00USD 0SEC filing ↗
2026-05-22KAVANAGH SARAH BAward / grant (A)Common Shares, No Par Value45,871USD 0.00USD 0SEC filing ↗
2026-05-22Garcia Christian AAward / grant (A)Common Shares, No Par Value45,871USD 0.00USD 0SEC filing ↗
2026-05-22GOETTLER MICHAELAward / grant (A)Common Shares, No Par Value45,871USD 0.00USD 0SEC filing ↗
2026-05-19Lee Frank D.Sale (S)Common Shares, No Par Value24,456USD 5.43USD 132,796SEC filing ↗
2026-03-03Carson SeanaSale (S)Common Shares, No Par Value4,420USD 5.77USD 25,503SEC filing ↗
2026-03-02Carson SeanaSale (S)Common Shares, No Par Value6,856USD 5.78USD 39,628SEC filing ↗
2026-03-02Carson SeanaJ (J)Common Shares, No Par Value137,922USD 5.95USD 820,636SEC filing ↗
2026-03-02Carson SeanaTax withholding (F)Common Shares, No Par Value16,973USD 5.95USD 100,989SEC filing ↗
2026-03-02APPIO THOMASJ (J)Common Shares, No Par Value1,137,862USD 5.95USD 6,770,279SEC filing ↗
2026-03-02APPIO THOMASTax withholding (F)Common Shares, No Par Value83,705USD 5.95USD 498,045SEC filing ↗
2026-02-27Charhon Jean-JacquesTax withholding (F)Common Shares, No Par Value49,060USD 5.93USD 290,926SEC filing ↗
2026-02-27Carson SeanaTax withholding (F)Common Shares, No Par Value26,326USD 5.93USD 156,113SEC filing ↗
2026-02-27APPIO THOMASTax withholding (F)Common Shares, No Par Value83,093USD 5.93USD 492,741SEC filing ↗
2026-02-27Carson SeanaSale (S)Common Shares, No Par Value8,388USD 5.95USD 49,909SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerBHC
CIK0000885590
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNYSE

Data coverage

Local Form 4 history505 transaction lines from 2020-01-03 to 2026-09-30
31 P purchase lines · 36 S sale lines · 438 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.